Stefan G Hofmann Selected Research

Anxiety Disorders (Anxiety Disorder)

1/2020	Biofeedback and Neurofeedback for Anxiety Disorders: A Quantitative and Qualitative Systematic Review.
12/2019	Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
6/2018	Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review.
1/2018	Rethinking avoidance: Toward a balanced approach to avoidance in treating anxiety disorders.
7/2015	Yoga-enhanced cognitive behavioural therapy (Y-CBT) for anxiety management: a pilot study.
7/2015	Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
1/2015	D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update.
1/2015	Neuroenhancement of Exposure Therapy in Anxiety Disorders.
6/2014	Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial.
5/2014	Effect of pharmacotherapy for anxiety disorders on quality of life: a meta-analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan G Hofmann Research Topics

Disease

29	Anxiety Disorders (Anxiety Disorder) 01/2020 - 11/2006
20	Social Phobia 01/2020 - 01/2006
8	Panic Disorder (Panic Attack) 01/2020 - 06/2007
5	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2017 - 01/2008
4	Agoraphobia 01/2020 - 06/2007
3	Phobic Disorders (Phobia) 05/2014 - 03/2006
2	Pain (Aches) 07/2019 - 11/2010
1	Anhedonia 12/2020
1	Specific Phobia 01/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 06/2019
1	Gambling (Pathological Gambling) 06/2019
1	Mood Disorders (Mood Disorder) 01/2015
1	Arachnophobia 05/2014
1	Acrophobia 05/2014
1	Mental Disorders (Mental Disorder) 01/2014
1	Confusion (Bewilderment) 09/2013
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 10/2011
1	Body Dysmorphic Disorders (Body Dysmorphic Disorder) 12/2010
1	Fibromyalgia (Fibrositis) 11/2010
1	Neoplasms (Cancer) 04/2010
1	Alcoholism (Alcohol Abuse) 04/2010
1	Depressive Disorder (Melancholia) 11/2009
1	Dizziness (Lightheadedness) 01/2009
1	Tuberculosis (Tuberculoses) 11/2006
1	Personality Disorders (Personality Disorder) 07/2004

Drug/Important Bio-Agent (IBA)

24	Cycloserine (Seromycin)FDA Link 01/2020 - 03/2006
4	Nootropic Agents (Nootropics)IBA 07/2015 - 08/2011
4	Anti-Anxiety Agents (Anxiolytics)IBA 01/2015 - 09/2007
3	Oxytocin (Pitocin)FDA LinkGeneric 01/2017 - 01/2014
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2013 - 03/2006
3	N-Methylaspartate (NMDA)IBA 06/2013 - 01/2012
3	Pharmaceutical PreparationsIBA 11/2010 - 11/2006
2	ElementsIBA 12/2020 - 01/2018
2	Yohimbine (Yocon)IBA 06/2014 - 01/2014
2	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2014 - 01/2014
1	Topiramate (Topamax)FDA LinkGeneric 06/2019
1	LithiumIBA 06/2019
1	Narcotic Antagonists (Opioid Antagonists)IBA 06/2019
1	Excitatory Amino Acid AgentsIBA 06/2019
1	BenzodiazepinesIBA 06/2018
1	Antidepressive Agents (Antidepressants)IBA 01/2017
1	D 53IBA 06/2014
1	GlucocorticoidsIBA 05/2014
1	Adenosine Monophosphate (AMP)IBA 02/2014
1	Modafinil (Provigil)FDA Link 01/2014
1	CatecholaminesIBA 01/2014
1	Glutamate Receptors (Glutamate Receptor)IBA 05/2012
1	Glycine Plasma Membrane Transport ProteinsIBA 05/2012
1	N- methyl- N- (6- methoxy- 1- phenyl- 1,2,3,4- tetrahydronaphthalen- 2- ylmethyl)aminomethylcarboxylic acidIBA 05/2012
1	Cocaine (Cocaine HCl)IBA 01/2012
1	Fluvoxamine (Luvox)FDA LinkGeneric 10/2011
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 04/2011
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 12/2010
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 04/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2006

Therapy/Procedure

17	Therapeutics 01/2020 - 01/2006
8	Drug Therapy (Chemotherapy) 02/2017 - 06/2007
2	Aftercare (After-Treatment) 05/2014 - 07/2004
1	Neurofeedback 01/2020
1	Psychology Biofeedback (Biofeedback) 01/2020
1	Analgesia 07/2019
1	Meditation 01/2015
1	Precision Medicine 01/2014
1	Cognitive Training 10/2010
1	Treatment Delay 01/2009